Home › Funds › South Street Advisors LLC › HALO
South Street Advisors LLC position in HALO
HALOZYME THERAPEUTICS INC · Health Care
South Street Advisors LLC reported holding 238,539 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$26.3M, representing 3.46% of its reported portfolio and ranking #9 among its reported holdings. South Street Advisors LLC has disclosed HALO holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How South Street Advisors LLC's HALO position evolved
South Street Advisors LLC first disclosed a stake in HALO in Q3 2024 at 171,415 shares (US$9.8M). The position peaked in Q3 2026 at 238,539 shares, worth US$26.3M. Across 9 filings, South Street Advisors LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 238,539 shares valued at US$26.3M. Notable position changes include a 34% increase in Q4 2024 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 171.41K | $9.81M | New |
| Q4 2024 | 229.76K | $10.99M | Add |
| Q1 2025 | 243.61K | $15.54M | Add |
| Q2 2025 | 241.27K | $12.55M | Reduce |
| Q3 2025 | 247.85K | $18.18M | Add |
| Q4 2025 | 231.76K | $15.60M | Reduce |
| Q1 2026 | 232.94K | $15.05M | Add |
| Q2 2026 | 238.69K | $18.68M | Add |
| Q3 2026 | 238.54K | $26.33M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HALO and 13F data
HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$178.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HALO
- CONGRESS ASSET MANAGEMENT CO 2.28M sh · $251.89M · Q3 2026
- SNYDER CAPITAL MANAGEMENT L P 2.40M sh · $187.54M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.62M sh · $178.46M · Q3 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 1.58M sh · $174.27M · Q3 2026
- Stephens Investment Management Group LLC 1.41M sh · $156.00M · Q3 2026
- GW&K Investment Management, LLC 1.14M sh · $125.86M · Q3 2026
- WASATCH ADVISORS LP 1.05M sh · $115.88M · Q3 2026
- Boston Trust Walden Corp 1.04M sh · $114.35M · Q3 2026
- LMR Partners LLP 45.00M sh · $65.81M · Q2 2026
More on South Street Advisors LLC
FAQ
How long has South Street Advisors LLC held HALO?
South Street Advisors LLC has disclosed HALO holdings in 9 of the last 9 reported quarters, going back to Q3 2024.
What is South Street Advisors LLC's current position in HALO?
As of Q3 2026, South Street Advisors LLC holds 238.54K shares of HALO (HALOZYME THERAPEUTICS INC), valued at $26.33M, representing 3.46% of its reported portfolio and ranking #9.
Has South Street Advisors LLC been buying or selling HALO?
In the latest 13F filing (Q3 2026), South Street Advisors LLC held unchanged its position in HALO. The position peaked in Q3 2026 at 238.54K shares.
Which other funds hold HALO?
Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, SNYDER CAPITAL MANAGEMENT L P, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.